1 . This natural ligand of the vitamin D receptor (VDR) regulates expressions of various genes including that encoding catabolic CYP24A1 through the VDR. Other activities mediated via the VDR include anti-inflammation, anti-proliferation, pro-differentiation, pro-apoptosis, immunomodulation, mineral homeostasis and anti-angiogenesis 2-4 . In addition, D 3 can also be activated by a novel metabolic pathway initiated by CYP11A1 (P450scc) . It also inhibits cell growth and shows potent anti-leukemic and anti-melanoma activities, while displaying less calcemic (toxic) effect than 1,25(OH) 2 D 3 7-10 . In addition, 1,20S(OH) 2 D 3 was found in human epidermis suggesting an endogenous role in the skin 11 . However, the lack of detailed information on the interactions between 1,20S(OH) 2 D 3 and VDR makes it difficult to understand its
Results and Discussion

Retrosynthesis of 1,20S(OH) 2 D 3 .
A retrosynthetic strategy including a common 1α-OH intermediate 3 was proposed (Fig. 2) . The D 3 -like structure could be obtained from UVB transformation of 2 [12] [13] [14] , of which the 20S-OH and side chain could be achieved by Grignard reaction of 3 [12] [13] [14] [15] . Introduction of 1α-OH to 4 could be carried out by a multi-step conversion following the synthesis of androstenolone 16 .
Synthesis of 1,20S(OH)
D 3 . The synthesis (Fig. 3 ) started with deacetylation and TBS protection of pregnenolone acetate (4) to give intermediate 6. NaBH 4 treatment of 6 selectively afforded the 20 R epimer as a major product which was then protected with an acetyl group to go through the DDQ oxidation safely (75% yield) to produce intermediate 10. After replacing 20-OAc with 20-OTBS, a 1α,2α-epoxide group was introduced by adding KOH and H 2 O 2 solution to afford intermediate 13 (73%), followed by Birch reduction to give 1α,3β-diol 14 (61%) as a major product [16] [17] [18] . To confirm the 1α-OH formation, 14 was protected with an acetyl group to produce 15, which was characterized by 1D and 2D NMR spectrometry, and crystalized from hexane for X-ray structure analysis (see Supplementary Fig. S2 ). After removal of 20-OTBS, intermediate 16 was oxidized by DMP to 1α,3β-diacetoxypregn-5-en-20-one (3, 95%), which was then transformed into the 5,7-diene 7DHC intermediate (17, 52%) following a well-established procedure [12] [13] [14] . To avoid potential separation problems caused by acetyl protection after Grignard reaction, ester hydrolysis was carried out prior to Grignard reaction (87%) to afford 1α,20S-7DHC (2) where the formation of 20S confirmation was discussed in previous reports [12] [13] [14] . UVB irradiation of 2 in ethyl ether followed by pre-vitamin D 3 isomerization afforded the desired product 1 (13%), which was compared with its enzymatic counterpart after HPLC separation.
Pregnenolone acetate (4) has often been used as the starting material for 20S(OH)D 3 analogs [12] [13] [14] , in which 1α-hydroxylation was necessary to display potent stimulation of the VDR 12, 13 . Owing to the lack of appropriate 1α-OH intermediates, the production of 1α-OH derivatives of 20S(OH)D 3 analogs was dependent on the purification of recombinant CYP27B1. The limited amount of 1α-OH derivatives that could be made was thus a hurdle for extensive biological testing. The production of 1α,3β-diacetoxypregn-5-en-20-one (3) in this report enables production of various analogs of 1,20S(OH) 2 D 3 for future studies.
We experienced inconsistent yields during the Birch reduction of epoxide 13 in the initial trials. In fact, the addition of NH 4 Cl (a quenching step) is the key to the success of this reaction. Quick addition (<10 min) of NH 4 Cl gave predominantly intermediate 14a, whereas slow addition (>2 h) afforded mainly the desired product 14. To our knowledge, 14a as a semi-reduced intermediate was obtained and characterized for the first time.
HPLC showed matched retention times of chemical and enzymatic 1,20S(OH) 2 D 3 . In addition to the UV spectra and NMR identification (Supplementary Information), the chemically synthesized 1,20S(OH) 2 D 3 was analysed by HPLC under two different solvent systems, either an acetonitrile in water gradient or a methanol in water gradient. We conclude that the chemically synthesized 1,20S(OH) 2 D 3 and the enzymatically produced counterpart are identical on the basis of their UV and NMR spectra, as well as their HPLC retention times (Fig. 4) . Co-migration of the chemically and enzymatically synthesized 1,20S(OH) 2 D 3 was further confirmed by chromatography of a mixture of the two (see Supplementary Information).
Identification of 15 as having a 1α-OH by NMR analysis. To identify the formation of the 1α-hydroxyl, the structure of intermediate 15 was characterized from its NMR spectra (Supplementary Information). The NOESY spectrum of 15 gave a strong NOE integral (0.42, see Supplementary Fig. S1 ) of 1H β to 19-CH 3 , using the NOE integral of 1H β to 2H β as an internal reference. In contrast, the NOE signal of 1H β to 2H α was not observed, suggesting the presence of 1α-OAc group in 15.
Confirmation of 15 by X-ray crystallographic analysis. To confirm the structure of 15, crystals were produced in hexane for X-ray crystallographic analysis (Supplementary Information). The X-ray structure of 15 (CCDC code: 1527430, Fig. 3 ) confirmed its absolute structure as the desired product reported in the Fig. 3 . An additional difference in the structures is that the 20S-OH forms a Van der Waals interaction with Val300. While most of the Van der Waals interactions are maintained, the side chain and terminal methyl groups that are differently positioned to interact differently with some of the residues ( VDR translocation activity. 1,25(OH) 2 D 3 binds to cytosolic or membrane-assocoated VDR 3 , then translocation of 1,25(OH) 2 D 3 -bound VDR from the cytoplasm to the nucleus is a key step to exert its gene-regulatory effects 1, 3 . In SKMEL-188 melanoma cells transduced with pLenti-CMVVDR-EGFP-pgk-puro 21 , both 1,20S(OH) 2 affects VDR target genes through VDR activation, expression of VDR, CYP24A1, TRPV6 and CYP27B1 genes at the mRNA level was determined in HaCaT cells (Fig. 6B) . 1,20S(OH) 2 D 3 was capable of mildly upregulating the expression (1.6-fold) of the gene encoding its own receptor, the VDR, while being moderately stronger than 1,25(OH) 2 D 3 (1.3-fold) and comparable to 22-Oxa (1.7-fold). 1,25(OH) 2 D 3 is known to induce expression of the vitamin D catabolic enzyme, CYP24A1 14, 22 . Similarly, 1,20S(OH) 2 D 3 strongly stimulates CYP24A1 mRNA levels 34-fold, as compared to 10-fold for 1,25(OH) 2 D 3 and 78-fold for 22-Oxa. In addition, TRPV6 encoding an intestinal calcium channel is also a well-known target of VDR for mineral homeostasis 14, 23 . The mRNA levels of TRPV6 were increased by 1.4-, 1.4-and 2.6-fold for 1,20S(OH) 2 . This study provides a molecular basis for the rational design and practical synthesis of novel 1,20S(OH) 2 D 3 analogs that interact with VDR for future drug development. 1,20S(OH) 2 D 3 was successfully chemically synthesized for the first time, providing ample material for further characterization of its biological activities, including animal studies in the future. The 1α,3β-diacetoxypregn-5-en-20-one (3) intermediate can serve as a common precursor for production of other 1,20S(OH) 2 D 3 analogs which will facilitate the synthesis of similar secosteroids containing a 1α-OH group.
Methods
General procedures. Reagents and solvents for the synthesis were anhydrous (purchased or self-dried) to ensure good product yield. Solvents used for separations were ACS chemical grade, purchased from commercial sources and used upon arrival. NH 4 Cl was sublimed in our lab for Birch reduction. Reactions for light sensitive compounds (7DHC or D 3 structures) were protected from light by wrapping flasks with aluminum foil, and were monitored under UV lights. Moisture-sensitive reactions were carried out under argon gas in flame-dried flasks. Reactions for non-UV active compounds were visualized on TLC by 5% phosphomolybdic acid in ethanol. All NMR data were collected on a Bruker Avance III 400 MHz NMR or a Varian Inova 500 MHz NMR. Samples were dissolved in 0.5 mL CDCl 3 , methanol-d 4 , DMSO-d 6 or actone-d 6 , and NMR data were collected at r.t. Mass spectra of compounds were acquired using a Bruker LC-IT-MS system with an ESI source. High-resolution MS spectra and extracted ion chromatogram (EIC) were obtained using a Waters ACQUITY UPLC I-Class System equipped with a Xevo G2-S QTof mass spectrometer based on our previously reported conditions 26, 27 . Reaction mixtures were extracted with ethyl acetate, DCM or hexanes, washed with aqueous Na 2 CO 3 , brine, and water, and then dried over anhydrous Na 2 SO 4 . The solution was transferred to a round-bottom flask and dried by rotary evaporator. The purities of final products were determined by HPLC as >98% (Fig. 4) .
Crystallization of intermediate 15.
To a clean test tube (13 × 100 mm), 18 mg of compound 15 powder and 3 mL anhydrous n-hexane were added. The tube was shaken until the solid was completely dissolved, then sealed with 5 layers of sealing film (Para film) membrane. The resulting solution was allowed to stand in a quiet environment for 10 days, by which time the hexane had evaporated, leaving crystals of 15 which were collected for crystallographic analysis (Supplementary Information).
Crystallization and structural analysis of 1,20S(OH) 2 D 3 -VDR complex. cDNA encoding zVDR LBD (156-453 AA) was subcloned into pET28b vector to generate an N-terminal His-tag fusion protein.
Purification was carried out as previously described, including metal affinity chromatography and gel filtration 28 . The protein was concentrated using Amicon ultra-30 (Millipore) to 3-7 mg/mL and incubated with a two-fold excess of ligand and a three-fold excess of the coactivator SRC-1 peptide (686-RHKILHRLLQEGSPS-698). Crystals were obtained in 50 mM Bis-Tris pH 6.5, 1.6 M lithium sulfate and 50 mM magnesium sulfate. Protein crystals were mounted in a fiber loop and flash-cooled under a nitrogen flux after cryo-protection with 20% glycerol. Data collection from a single frozen crystal was performed at 100 K on the ID23-1 beamline at ESRF (France). The raw data were processed and scaled with the HKL2000 program suite 29 . The crystals belong to the space group P6 5 22 , with one LBD complex per asymmetric unit. The structure was solved and refined using BUSTER 30 , Phenix 31 and iterative model building using COOT 32 . Crystallographic refinement statistics are presented in Supplementary Table S9 . All structural figures were prepared using PyMOL (www.pymol.org/). 
Biosynthesis of 1,20S(OH)
. HPLC comparison was determined by using an Agilent HPLC 1100 system and a Phenomenex Luna-PFP C 18 column (5 µm, 250 mm × 4.6 mm, Torrance, CA) at 25 °C and a flow rate of 1.0 mL/min. MeCN: H 2 O and MeOH: H 2 O were used as mobile phases with a gradient comprising 50-100% organic solvent for 30 min. 263 nm was used to display chromatograms.
VDRE-reporter assay. HaCat, Caco-2 and Jurkat cells were transduced by lentiviral VDRE-reporter (luciferase) vector [12] [13] [14] [15] . Caco-2 cells were grown in Dulbecco's Modified Eagle Medium (DMEM) containing 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin/amphotericin antibiotic solution (Ab) (Sigma-Aldrich, St. Louis, MO). HaCaT cells were grown in DMEM supplemented with 5% FBS and 1% Ab. Jurkat cells were grown in RPMI 1640 medium containing 10% FBS and 1% Ab. All cells were cultured at 37 °C in a humidified atmosphere containing 5% CO 2 . All cell lines were selected for at least one week by medium containing additional 1.0 µg/mL puromycin before treatment with secosteroid. Each cell line was then plated in a 96-well plate (10,000 cells/100 µL medium/well) using FBS-free media and incubated for 24 h. 1,20S(OH) 2 D 3 , 1,25(OH) 2 D 3 and 22-Oxa at a series of concentrations in 10% DMSO were added separately to 96-well plates (1.0 µL/well), while 10% DMSO was used as control. After 24 h incubation, 100 µL of ONE-Glo TM Luciferase Assay System (Promega, Madison, WI) was added to each well. After 5 min at r.t., the signal was recorded by a BioTek Synergy HT microplate reader (BioTek Instruments, Inc., Winooski, VT, US). All concentrations of secosteroids were tested in triplicate.
VDR translocation assay. The effects of 1,20 S(OH) 2 D 3 on VDR translocation from the cytoplasm to the nucleus were tested on the previously described SKMEL-188 cell model 21, 33 , using cells stably transduced with pLenti-CMV-VDREGFP-pgk-puro (VDR and EGFP expressed as fusion protein) 34 . Cells were treated with secosteroids (up to 100 nM) for 90 min followed by analysis with Cytation 5 (BioTek, Winooski, VT, US). Translocation to the nucleus was determined by counting cells with a fluorescent nucleus and the results are presented as the percentage of the total cells that displayed nuclear staining, as described previously 21 . The data were obtained from at least two separate experiments, with images taken in the central area from at least three different wells and counted as described 21, 34 .
Real-time PCR assay. HaCaT cells were seeded in 60 mm dishes (1 million/dish) in 10 mL DMEM supplemented with 5% FBS and 1% Ab. After overnight incubation they were cultured in FBS-free medium for another 12 h to synchronize the cells. The media were then removed and secosteroids in DMEM (5% FBS and 1% Ab) with a concentration of 100 nM were added to the dishes. After 24 h incubation, media were removed, and 10 mL PBS was used to wash the dish. Cells were then detached by trypsin, centrifuged in Eppendorf tubes, washed with PBS (5 mL), and stored at −80 °C. Absolutely RNA Miniprep Kit (Stratagene, La Jolla, CA, USA) was used to isolate the RNA, and Transcriptor First Strand cDNA Synthesis Kit (Roche Inc., Mannheim, Germany) was used for reverse transcription (100 ng RNA/reaction). Real-time PCR was carried out using cDNA which was diluted 10-fold in sterile water and a SYBR Green PCR Master Mix. The forward reverse primers for VDR, CYP24A1, TRPV6 and CYP27B1 genes were designed based on the rat and mouse sequences using Primer Quest software (Integrated Device Technology, San Jose, CA, USA). Reactions (n = 3) were performed at 50 °C for 2 min, 95 °C for 10 min and then 40 cycles of 95 °C for 15 s, 60 °C for 30 s and 72 °C for 30 s. Data were collected and analyzed on a Roche Light Cycler 480. Using a comparative Ct method 25 , the amount of the final amplified product was normalized to the amount of β-actin as a housekeeping gene.
IFNγ production assay. All EtOH vehicle + anti-CD3e MOAB (0.08 μg/mL) and [IFNγ] in each of the cultures containing D 3 analog was analyzed by one way ANOVA Sigma. The amount of EtOH in the EtOH + PBS and EtOH + anti-CD3e MOAB culture was equal to that in the cultures of the D 3 analogs at a level of 10 −9 M. Culture medium was RPMI 1640 supplemented with 9% charcoal stripped fetal bovine serum, non-essential amino acids, HEPES buffer Glutamax, penicillin 100 μg/mL, streptomycin 100 μg/mL, fungizone 1 μg/mL (GIBCO, Grand Island, NY) and 50 μM β-mercaptoethanol (Sigma, St. Louis, MO) 35 .
IL1β production assay. Splenocytes were isolated from 7-week old C57BL/6 female mice and cultured at 2 × 10 6 /mL, 500 μL/well, for 24 h at 37 °C in a humidified atmosphere. The vitamin D analogs or EtOH vehicle were added to the splenocyte cultures 2 h prior to addition of Lipopolysaccharide W E. coli 055:B5 (LPS) (Difco Lab. Defrost MI) 100 ng/mL or PBS vehicle. Harvested supernatants were analyzed for levels of murine IL1β by ELISA (R & D Systems Minneapolis, MN) according to the manufacturer's instructions. Results are expressed as mean IL1β concentration ± SEM of triplicate determinations (pg/mL) of culture supernatant. The amount of EtOH in the EtOH + PBS and EtOH + LPS culture was equal to that in the cultures of the vitamin D analogs at a level of 10 -7 M. Culture medium was RPMI 1640 supplemented with 9% charcoal stripped fetal bovine serum, non-essential amino acids, HEPES buffer Glutamax, penicillin 100 μg/mL, streptomycin 100 μg/mL, fungizone 1 μg/mL (GIBCO, Grand Island, NY) and 50 μM β-mercaptoethanol (Sigma, St. Louis, MO). The difference in [IL1β] between control and D 3 analog treatment was analyzed by one way ANOVA (Sigma Plot 13.0).
